Entity Common Stock, Shares Outstanding of ADC Therapeutics SA from 31 Dec 2020 to 31 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ADC Therapeutics SA quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Dec 2020 to 31 Oct 2025.
  • ADC Therapeutics SA Entity Common Stock, Shares Outstanding for the quarter ending 31 Oct 2025 was 123,877,111, a 28% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

ADC Therapeutics SA Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 123,877,111 +27,187,494 +28% 31 Oct 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 112,499,395 +15,851,945 +16% 01 Aug 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 99,083,838 +16,554,289 +20% 01 Mar 2025 10-K 27 Mar 2025 2024 FY
Q3 2024 96,689,617 01 Nov 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 96,647,450 01 Aug 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 82,529,549 01 Mar 2024 10-K 13 Mar 2024 2023 FY
Q4 2022 80,642,527 +3,832,049 +5% 31 Dec 2022 20-F 15 Mar 2023 2022 FY
Q4 2021 76,810,478 +88,935 +0.12% 31 Dec 2021 20-F 17 Mar 2022 2021 FY
Q4 2020 76,721,543 31 Dec 2020 20-F 18 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.